These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 1629956)

  • 1. Complementation of murine cells for human immunodeficiency virus envelope/CD4-mediated fusion in human/murine heterokaryons.
    Dragic T; Charneau P; Clavel F; Alizon M
    J Virol; 1992 Aug; 66(8):4794-802. PubMed ID: 1629956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The block to HIV-1 envelope glycoprotein-mediated membrane fusion in animal cells expressing human CD4 can be overcome by a human cell component(s).
    Broder CC; Dimitrov DS; Blumenthal R; Berger EA
    Virology; 1993 Mar; 193(1):483-91. PubMed ID: 8438583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human immunodeficiency virus envelope glycoprotein/CD4-mediated fusion of nonprimate cells with human cells.
    Ashorn PA; Berger EA; Moss B
    J Virol; 1990 May; 64(5):2149-56. PubMed ID: 2109100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amino acid changes in the fourth conserved region of human immunodeficiency virus type 2 strain HIV-2ROD envelope glycoprotein modulate fusion.
    Keller R; Peden K; Paulous S; Montagnier L; Cordonnier A
    J Virol; 1993 Oct; 67(10):6253-8. PubMed ID: 8371358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fusion of human immunodeficiency virus-infected cells with uninfected cells.
    Lifson JD
    Methods Enzymol; 1993; 221():3-12. PubMed ID: 8361381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The phorbol ester phorbol myristate acetate inhibits human immunodeficiency virus type 1 envelope-mediated fusion by modulating an accessory component(s) in CD4-expressing cells.
    Golding H; Manischewitz J; Vujcic L; Blumenthal R; Dimitrov DS
    J Virol; 1994 Mar; 68(3):1962-9. PubMed ID: 7906314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4 molecules with a diversity of mutations encompassing the CDR3 region efficiently support human immunodeficiency virus type 1 envelope glycoprotein-mediated cell fusion.
    Broder CC; Berger EA
    J Virol; 1993 Feb; 67(2):913-26. PubMed ID: 8419649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A seven-transmembrane domain receptor involved in fusion and entry of T-cell-tropic human immunodeficiency virus type 1 strains.
    Berson JF; Long D; Doranz BJ; Rucker J; Jirik FR; Doms RW
    J Virol; 1996 Sep; 70(9):6288-95. PubMed ID: 8709256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different requirements for membrane fusion mediated by the envelopes of human immunodeficiency virus types 1 and 2.
    Dragic T; Alizon M
    J Virol; 1993 Apr; 67(4):2355-9. PubMed ID: 8095307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors involved in entry of the human immunodeficiency virus type 1 into permissive cells: lack of evidence of a role for CD26.
    Lazaro I; Naniche D; Signoret N; Bernard AM; Marguet D; Klatzmann D; Dragic T; Alizon M; Sattentau Q
    J Virol; 1994 Oct; 68(10):6535-46. PubMed ID: 7916060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of HIV env gene in a human T cell line for a rapid and quantifiable cell fusion assay.
    Moir S; Poulin L
    AIDS Res Hum Retroviruses; 1996 Jun; 12(9):811-20. PubMed ID: 8738433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteinase-resistant factors in human erythrocyte membranes mediate CD4-dependent fusion with cells expressing human immunodeficiency virus type 1 envelope glycoproteins.
    Dragic T; Picard L; Alizon M
    J Virol; 1995 Feb; 69(2):1013-8. PubMed ID: 7815477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of an HIV cell-cell fusion assay by using two genetically modified HeLa cell lines and reporter gene.
    Sakamoto T; Ushijima H; Okitsu S; Suzuki E; Sakai K; Morikawa S; Müller WE
    J Virol Methods; 2003 Dec; 114(2):159-66. PubMed ID: 14625051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a novel high-throughput surrogate assay to measure HIV envelope/CCR5/CD4-mediated viral/cell fusion using BacMam baculovirus technology.
    Jenkinson S; McCoy DC; Kerner SA; Ferris RG; Lawrence WK; Clay WC; Condreay JP; Smith CD
    J Biomol Screen; 2003 Aug; 8(4):463-70. PubMed ID: 14567799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human immunodeficiency virus type 1 membrane fusion mediated by a laboratory-adapted strain and a primary isolate analyzed by resonance energy transfer.
    Litwin V; Nagashima KA; Ryder AM; Chang CH; Carver JM; Olson WC; Alizon M; Hasel KW; Maddon PJ; Allaway GP
    J Virol; 1996 Sep; 70(9):6437-41. PubMed ID: 8709277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importance of membrane fusion mediated by human immunodeficiency virus envelope glycoproteins for lysis of primary CD4-positive T cells.
    LaBonte JA; Patel T; Hofmann W; Sodroski J
    J Virol; 2000 Nov; 74(22):10690-8. PubMed ID: 11044113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fusogenic mechanisms of enveloped-virus glycoproteins analyzed by a novel recombinant vaccinia virus-based assay quantitating cell fusion-dependent reporter gene activation.
    Nussbaum O; Broder CC; Berger EA
    J Virol; 1994 Sep; 68(9):5411-22. PubMed ID: 8057423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monocyte-lymphocyte fusion induced by the HIV-1 envelope generates functional heterokaryons with an activated monocyte-like phenotype.
    Martínez-Méndez D; Rivera-Toledo E; Ortega E; Licona-Limón I; Huerta L
    Exp Cell Res; 2017 Mar; 352(1):9-19. PubMed ID: 28132881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antagonistic effect of interferon-gamma on tat-induced transactivation of HIV long terminal repeat.
    Emilie D; Maillot MC; Nicolas JF; Fior R; Galanaud P
    J Biol Chem; 1992 Oct; 267(29):20565-70. PubMed ID: 1400376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of human immunodeficiency virus envelope gene sequences influencing viral entry into CD4-positive HeLa cells, T-leukemia cells, and macrophages.
    Chesebro B; Nishio J; Perryman S; Cann A; O'Brien W; Chen IS; Wehrly K
    J Virol; 1991 Nov; 65(11):5782-9. PubMed ID: 1920616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.